Bron, France

Herve Petite

This inventor holds 1 USPTO granted patent. Top assignee: Bioetica. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Herve Petite. Retrieved from https://idiyas.com/inventor/herve-petite-3888p9zz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Herve Petite: Innovator in Collagen Cross-Linking

Introduction

Herve Petite is a notable inventor based in Bron, France. He has made significant contributions to the field of biomedical engineering, particularly in the area of collagen cross-linking.

Latest Patents

Herve Petite holds a patent for a "Process for cross-linking of collagen by diphenylphosphorylazide." This innovative method has potential applications in various medical fields, enhancing the properties of collagen for improved therapeutic outcomes.

Career Highlights

Herve is associated with Bioetica, a company focused on advancing biotechnological solutions. His work at Bioetica has positioned him as a key player in the development of new materials and processes that can benefit medical science.

Collaborations

Herve has collaborated with esteemed colleagues such as Alain Roger Huc and Philippe Menasche. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Herve Petite's contributions to the field of collagen cross-linking exemplify the impact of innovative thinking in biomedical engineering. His work continues to inspire advancements in medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…